Reduced susceptibility of Malaysian clinical isolates of Burkholderia pseudomallei to ciprofloxacin
Ciprofloxacin, a quinolone with good intracellular penetration may possibly be used for treatment of melioidosis caused by Burkholderia pseudomallei, but problems with resistance may be encountered. Amino acid substitutions in gyrA/gyrB have given rise to fluoroquinolone resistance in various microo...
Saved in:
Main Authors: | Liew, F.Y., Tay, S.T., Puthucheary, S.D. |
---|---|
Format: | Article |
Published: |
Malaysian Society of Parasitology and Tropical Medicine
2012
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/3402/ http://www.ncbi.nlm.nih.gov/pubmed/22433895 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enzymatic profiling of clinical and environmental isolates of Burkholderia pseudomallei
by: Liew, S.M., et al.
Published: (2012) -
Susceptibility of Burkholderia pseudomallei to tigecycline and other antimicrobials
by: Sam, I-Ching, et al.
Published: (2010) -
Sequence polymorphism and PCR-restriction fragment length polymorphism analysis of the flagellin gene of Burkholderia pseudomallei.
by: Tay, S.T., et al.
Published: (2010) -
Identification of Burkholderia pseudomallei Mimotope using Phage display approach
by: Chua, K.H., et al.
Published: (2008) -
DNA fingerprinting of human isolates of Burkholderia pseudomallei from different geographical regions of Malaysia
by: Chua, K.H., et al.
Published: (2010)